Profile: Dr Stephanie Adams

At the intersection of Sport Science and Psychology: meet Scottish Brain Sciences’ Head of Sports Science.

Partnership seeks early Alzheimer’s blood test

An agreement between Scottish Brain Sciences and a global leader in precision diagnostics is aiming to transform the ability of clinicians to identify the very earliest signs of Alzheimer’s Disease – long before symptoms can be seen.

The SBS Blog – Welcome our new Research Officer to the CEO!

Please join us in welcoming Dr Makis Tzioras to the SBS Team as Research Officer to the CEO! Read more about what he brings to Scottish Brain Sciences…

The SBS Blog – Welcome our new Senior Clinical Research Neurologist!

We are so happy to be able to welcome Dr Kristiina Rannikmae to the SBS Team as Senior Clinical Research Neurologist! Read more about what she brings to Scottish Brain Sciences…

The SBS Blog – Welcome our new Head of Laboratory Sciences!

Recently, we were thrilled to welcome Dr Alison Green to the Leadership Team as our Head of Laboratory Sciences! Read more about what she brings to Scottish Brain Sciences…

Donanemab marks start of “new story” in Alzheimer’s research

Professor Craig Ritchie has told an international Alzheimer’s conference that phase 3 clinical trial results for donanemab, the antibody drug designed to target and clear the amyloid plaques considered key to progression of Alzheimer’s disease, reveal the drug’s “profound” clinical effect. 

Scotland hosts second world brain health summit

Professor Craig Ritchie, CEO of Scottish Brain Sciences co-hosts the second international brain health summit in St Andrew’s, bringing together experts across the NHS, academia, and industry for a two-day conference.

The hope for a life-long healthy brain

Professor Ritchie spoke with The Times about the drive to advance research at a faster pace than manageable within the NHS.